Business Context and Reporting Period
This Form 8-K was filed by Neuralstem, Inc. on August 10, 2012. The report serves to announce the Company's financial results for the three and six months ended June 30, 2012. The specific financial data is contained within a press release attached as Exhibit 99.01, which is incorporated by reference.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are detailed in the referenced press release (Exhibit 99.01) rather than the body of this 8-K form.
Material Changes
The filing does not explicitly detail material changes versus prior periods within the text provided. It directs readers to the attached press release for the announcement of results for the periods ended June 30, 2012.
Guidance, Outlook, and Risks
The text does not provide specific guidance, outlook, management commentary, or risk factors. It notes that the information furnished under Item 2.02 and the accompanying exhibit shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, nor subject to the liability of such section.
Investor Verification Checklist
- Review Exhibit 99.01 (Press Release dated August 10, 2012) for actual revenue, net loss, and cash position figures.
- Verify the specific operational milestones or clinical trial updates mentioned in the press release.
- Confirm the Company's cash runway and funding status as detailed in the full financial report.
- Note that the 8-K text itself is a procedural filing referencing external data rather than a source of primary financial numbers.